Spared Motivational Modulation of Cognitive Effort in a Maternal Immune Activation Model of Schizophrenia Risk

被引:14
|
作者
Bates, Vanessa [1 ]
Maharjan, Ashim [1 ]
Millar, Jessica [1 ]
Bilkey, David K. [1 ]
Ward, Ryan D. [1 ]
机构
[1] Univ Otago, Dept Psychol, POB 56, Dunedin 9054, New Zealand
关键词
maternal immune activation; signaled reward probability; motivation; schizophrenia; poly I:C; NEURODEVELOPMENTAL ANIMAL-MODEL; NEGATIVE SYMPTOMS; DOPAMINERGIC HYPERFUNCTION; REWARD PROBABILITY; RAT MODEL; DEFICITS; INHIBITION; ETIOLOGY; IMPACT; MICE;
D O I
10.1037/bne0000230
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Maternal immune activation (MIA) during gestation is a significant risk factor for development of schizophrenia and other neurodevelopmental diseases. In animal models of this risk factor, MIA during pregnancy can produce offspring that recapitulate certain aspects of the behavioral and neurophysiological impairments seen in schizophrenia. Here, the authors tested the effect of polyinosinic-polycytidylic acid (poly I:C)-induced MIA in a task that explicitly assays the interaction between motivation and cognition. In our paradigm, discrimination accuracy during a sustained-attention task is differentially impacted by environmental cues that signal the probability of reward for accurate performance. Cognition-motivation interactions are implicated in producing functional impairments in patients. Therefore, to the extent that this MIA model recapitulates such impairments, the authors predicted impaired ability of reward-associated signals to modulate cognitive performance in MIA rat offpsring. Adult offspring of dams in which MIA was induced displayed impaired prepulse inhibition relative to controls, verifying a functional effect of poly I: C induction. Despite this deficit, there were no differences between MIA and control rats in any aspects of task learning or performance, including under extinction and reacquisition conditions. These results indicate that MIA spares functioning of some of the cognitive, motivational, and decision-making processes that are impacted in schizophrenia and suggest that MIA as an isolated manipulation does not model the full range and nuance of the cognitive and motivational impairments in the disease. The authors suggest that some aspects of the functional impairment in schizophrenia and other neurodevelopmental diseases may be better modeled using multiple "hit" models of disease risk.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 50 条
  • [31] Maternal Immune Activation by Poly I:C as a preclinical Model for Neurodevelopmental Disorders: A focus on Autism and Schizophrenia
    Haddad, Faraj L.
    Patel, Salonee, V
    Schmid, Susanne
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2020, 113 : 546 - 567
  • [32] The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia
    De Felice, Marta
    Melis, Miriam
    Aroni, Sonia
    Muntoni, Anna Lisa
    Fanni, Silvia
    Frau, Roberto
    Devoto, Paola
    Pistis, Marco
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (05) : 549 - 561
  • [33] PREVENTION OF POST-PUBERTAL SCHIZOPHRENIA-LIKE BEHAVIOR AND NEUROPATHOLOGY IN THE MATERNAL IMMUNE ACTIVATION MODEL
    Weiner, I.
    Piontkewitz, Y.
    Assaf, Y.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 140 - 140
  • [34] Maternal immune activation downregulates schizophrenia genes in the foetal mouse brain
    Handunnetthi, Lahiru
    Saatci, Defne
    Hamley, Joseph C.
    Knight, Julian C.
    BRAIN COMMUNICATIONS, 2021, 3 (04)
  • [35] Maternal immune activation and risk of Autism Spectrum Disorder
    Venegas, Carolina Heresi
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2019, 90 (05): : 555 - 558
  • [36] MATERNAL IMMUNE ACTIVATION IN MICE WITH HETEROZYGOUS KNOCKOUT OF THE SCHIZOPHRENIA RISK GENE NEUREGULIN 1: MODELLING GENE x ENVIRONMENT INTERACTION IN SCHIZOPHRENIA
    O'Leary, C.
    Desbonnet, L.
    O'Tuathaigh, C. M.
    Tighe, O.
    Clarke, N.
    Lai, D.
    Harvey, R.
    Waddington, J. L.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 : A49 - A49
  • [37] DOPAMINERGIC MODULATION OF IMPAIRED COGNITIVE ACTIVATION IN THE ANTERIOR CINGULATE CORTEX IN SCHIZOPHRENIA
    DOLAN, RJ
    FLETCHER, P
    FRITH, CD
    FRISTON, KJ
    FRACKOWIAK, RSJ
    GRASBY, PM
    NATURE, 1995, 378 (6553) : 180 - 182
  • [38] NICOTINIC CHOLINERGIC MODULATION OF THE FETAL BRAIN RESPONSE TO MATERNAL IMMUNE ACTIVATION
    Wu, Wei-Li
    Adams, C. E.
    Stevens, Karen
    Chow, K.
    Patterson, P. H.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S216 - S216
  • [39] Maternal quercetin supplementation improved lipopolysaccharide-induced cognitive deficits and inflammatory response in a rat model of maternal immune activation
    Abbasi, Hossein
    Ghavami-kia, Sina
    Davoodian, Nahid
    Davoodian, Najmeh
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 483
  • [40] Susceptibility and Resilience in a Mouse Model of Maternal Immune Activation
    Muller, Flavia
    Weber-Stadlbauer, Ulrike
    Meyer, Urs
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S342 - S342